InflaRx Research Development vs Operating Income Analysis

IFRX Stock

USD 2.36 0.05 2.16%

InflaRx NV financial indicator trend analysis is infinitely more than just investigating InflaRx NV recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether InflaRx NV is a good investment. Please check the relationship between InflaRx NV Research Development and its Operating Income accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in InflaRx NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy InflaRx Stock please use our How to Invest in InflaRx NV guide.

Research Development vs Operating Income

Research Development vs Operating Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of InflaRx NV Research Development account and Operating Income. At this time, the significance of the direction appears to have pay attention.

The correlation between InflaRx NV's Research Development and Operating Income is -0.96. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Operating Income in the same time period over historical financial statements of InflaRx NV, assuming nothing else is changed. The correlation between historical values of InflaRx NV's Research Development and Operating Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of InflaRx NV are associated (or correlated) with its Operating Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Operating Income has no effect on the direction of Research Development i.e., InflaRx NV's Research Development and Operating Income go up and down completely randomly.

Correlation Coefficient

-0.96

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Research Development

Operating Income

Operating Income is the amount of profit realized from InflaRx NV operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of InflaRx NV is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Most indicators from InflaRx NV's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into InflaRx NV current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in InflaRx NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy InflaRx Stock please use our How to Invest in InflaRx NV guide.Sales General And Administrative To Revenue is likely to rise to 212.95 in 2024, whereas Selling General Administrative is likely to drop slightly above 10.1 M in 2024.

InflaRx NV fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Long Term Debt Total	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Long Term Investments	Property Plant And Equipment Gross
Total Assets		-0.76	0.53	0.83	0.99	0.68	0.98	0.74	-0.58	-0.7	0.76	0.59	0.46	0.27	0.98	0.6	0.94	0.38	-0.76	-0.76	0.32	0.48	0.91	-0.51	0.4	0.56
Short Long Term Debt Total	-0.76		-0.45	-0.7	-0.84	-0.55	-0.84	-0.67	0.33	0.65	-0.63	-0.34	-0.38	-0.22	-0.73	-0.54	-0.83	-0.35	1.0	1.0	-0.31	-0.47	-0.8	0.91	-0.33	-0.52
Other Current Liab	0.53	-0.45		0.79	0.5	0.31	0.54	0.84	0.08	-0.77	0.24	-0.06	0.82	-0.17	0.37	0.51	0.61	0.81	-0.47	-0.46	0.26	0.94	0.73	-0.13	0.79	0.56
Total Current Liabilities	0.83	-0.7	0.79		0.8	0.52	0.82	0.97	-0.15	-0.9	0.73	0.16	0.75	-0.08	0.71	0.72	0.91	0.74	-0.71	-0.7	0.42	0.73	0.95	-0.34	0.68	0.73
Total Stockholder Equity	0.99	-0.84	0.5	0.8		0.69	1.0	0.72	-0.59	-0.68	0.75	0.6	0.43	0.3	0.98	0.57	0.95	0.34	-0.84	-0.84	0.3	0.46	0.9	-0.63	0.37	0.53
Other Liab	0.68	-0.55	0.31	0.52	0.69		0.68	0.5	-0.08	-0.44	0.56	0.08	0.22	-0.31	0.69	0.48	0.59	0.39	-0.54	-0.54	0.23	0.23	0.59	-0.41	0.17	0.39
Net Tangible Assets	0.98	-0.84	0.54	0.82	1.0	0.68		0.75	-0.57	-0.71	0.77	0.58	0.43	0.29	0.96	0.59	0.96	0.4	-0.84	-0.84	0.32	0.5	0.93	-0.62	0.37	0.55
Property Plant And Equipment Net	0.74	-0.67	0.84	0.97	0.72	0.5	0.75		-0.01	-0.9	0.67	0.02	0.7	-0.21	0.62	0.67	0.85	0.77	-0.68	-0.67	0.33	0.83	0.91	-0.31	0.63	0.68
Net Debt	-0.58	0.33	0.08	-0.15	-0.59	-0.08	-0.57	-0.01		-0.02	-0.27	-1.0	0.03	-0.88	-0.67	0.09	-0.44	0.4	0.32	0.33	0.12	0.08	-0.31	0.36	0.04	0.11
Retained Earnings	-0.7	0.65	-0.77	-0.9	-0.68	-0.44	-0.71	-0.9	-0.02		-0.68	0.0	-0.62	0.14	-0.59	-0.9	-0.81	-0.82	0.67	0.66	-0.67	-0.76	-0.9	0.31	-0.56	-0.9
Accounts Payable	0.76	-0.63	0.24	0.73	0.75	0.56	0.77	0.67	-0.27	-0.68		0.28	0.14	0.03	0.76	0.69	0.81	0.43	-0.64	-0.64	0.48	0.22	0.78	-0.41	0.06	0.64
Cash	0.59	-0.34	-0.06	0.16	0.6	0.08	0.58	0.02	-1.0	0.0	0.28		-0.02	0.88	0.67	-0.08	0.46	-0.38	-0.33	-0.34	-0.12	-0.06	0.32	-0.36	-0.03	-0.1
Non Current Assets Total	0.46	-0.38	0.82	0.75	0.43	0.22	0.43	0.7	0.03	-0.62	0.14	-0.02		-0.13	0.29	0.42	0.51	0.64	-0.4	-0.39	0.24	0.68	0.6	-0.07	1.0	0.48
Other Assets	0.27	-0.22	-0.17	-0.08	0.3	-0.31	0.29	-0.21	-0.88	0.14	0.03	0.88	-0.13		0.34	-0.19	0.19	-0.48	-0.22	-0.22	-0.07	-0.16	0.09	-0.35	-0.11	-0.17
Cash And Short Term Investments	0.98	-0.73	0.37	0.71	0.98	0.69	0.96	0.62	-0.67	-0.59	0.76	0.67	0.29	0.34		0.51	0.89	0.22	-0.73	-0.73	0.26	0.34	0.83	-0.53	0.23	0.46
Net Receivables	0.6	-0.54	0.51	0.72	0.57	0.48	0.59	0.67	0.09	-0.9	0.69	-0.08	0.42	-0.19	0.51		0.64	0.73	-0.55	-0.54	0.9	0.43	0.74	-0.25	0.37	0.99
Common Stock Total Equity	0.94	-0.83	0.61	0.91	0.95	0.59	0.96	0.85	-0.44	-0.81	0.81	0.46	0.51	0.19	0.89	0.64		0.53	-0.83	-0.83	0.34	0.61	0.98	-0.56	0.44	0.61
Common Stock Shares Outstanding	0.38	-0.35	0.81	0.74	0.34	0.39	0.4	0.77	0.4	-0.82	0.43	-0.38	0.64	-0.48	0.22	0.73	0.53		-0.37	-0.35	0.56	0.72	0.68	-0.02	0.6	0.75
Long Term Debt Total	-0.76	1.0	-0.47	-0.71	-0.84	-0.54	-0.84	-0.68	0.32	0.67	-0.64	-0.33	-0.4	-0.22	-0.73	-0.55	-0.83	-0.37		1.0	-0.32	-0.48	-0.81	0.9	-0.34	-0.53
Non Current Liabilities Total	-0.76	1.0	-0.46	-0.7	-0.84	-0.54	-0.84	-0.67	0.33	0.66	-0.64	-0.34	-0.39	-0.22	-0.73	-0.54	-0.83	-0.35	1.0		-0.31	-0.47	-0.8	0.9	-0.33	-0.52
Inventory	0.32	-0.31	0.26	0.42	0.3	0.23	0.32	0.33	0.12	-0.67	0.48	-0.12	0.24	-0.07	0.26	0.9	0.34	0.56	-0.32	-0.31		0.14	0.45	-0.11	0.22	0.91
Other Current Assets	0.48	-0.47	0.94	0.73	0.46	0.23	0.5	0.83	0.08	-0.76	0.22	-0.06	0.68	-0.16	0.34	0.43	0.61	0.72	-0.48	-0.47	0.14		0.7	-0.19	0.64	0.46
Other Stockholder Equity	0.91	-0.8	0.73	0.95	0.9	0.59	0.93	0.91	-0.31	-0.9	0.78	0.32	0.6	0.09	0.83	0.74	0.98	0.68	-0.81	-0.8	0.45	0.7		-0.5	0.53	0.72
Total Liab	-0.51	0.91	-0.13	-0.34	-0.63	-0.41	-0.62	-0.31	0.36	0.31	-0.41	-0.36	-0.07	-0.35	-0.53	-0.25	-0.56	-0.02	0.9	0.9	-0.11	-0.19	-0.5		-0.03	-0.22
Long Term Investments	0.4	-0.33	0.79	0.68	0.37	0.17	0.37	0.63	0.04	-0.56	0.06	-0.03	1.0	-0.11	0.23	0.37	0.44	0.6	-0.34	-0.33	0.22	0.64	0.53	-0.03		0.43
Property Plant And Equipment Gross	0.56	-0.52	0.56	0.73	0.53	0.39	0.55	0.68	0.11	-0.9	0.64	-0.1	0.48	-0.17	0.46	0.99	0.61	0.75	-0.53	-0.52	0.91	0.46	0.72	-0.22	0.43

Click cells to compare fundamentals

InflaRx NV Account Relationship Matchups

InflaRx NV fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	121.6M	88.2M	125.1M	102.4M	120.2M	106.8M
Short Long Term Debt Total	846.0K	559.0K	1.4M	1.4M	1.1M	1.1M
Other Current Liab	1.1M	117.7K	8.4M	7.7M	4.5M	2.8M
Total Current Liabilities	14.1M	10.1M	18.8M	13.0M	16.8M	10.7M
Total Stockholder Equity	107.1M	77.9M	105.3M	88.3M	102.7M	86.6M
Other Liab	67.9K	39.0K	33.3K	35.0K	40.3K	37.6K
Net Tangible Assets	151.2M	106.7M	77.5M	105.0M	120.8M	81.2M
Property Plant And Equipment Net	1.4M	955.0K	1.7M	1.6M	1.4M	988.9K
Net Debt	(32.3M)	(25.4M)	(24.8M)	(14.9M)	(11.6M)	(12.2M)
Retained Earnings	(134.4M)	(168.3M)	(214.0M)	(243.5M)	(286.1M)	(271.8M)
Accounts Payable	12.4M	8.3M	1.7M	5.0M	12.0M	6.4M
Cash	33.1M	26.0M	26.2M	16.3M	12.8M	12.1M
Non Current Assets Total	2.6M	1.9M	29.5M	5.0M	10.7M	6.3M
Non Currrent Assets Other	452.2K	353.5K	336.6K	308.1K	283.2K	381.2K
Other Assets	(2.0)	353.5K	336.6K	(8.9K)	(8.0K)	(7.6K)
Cash And Short Term Investments	115.5M	81.1M	83.4M	81.8M	90.3M	93.4M
Common Stock Total Equity	2.9M	3.1M	3.1M	3.4M	3.9M	2.3M
Common Stock Shares Outstanding	26.0M	27.1M	41.6M	44.2M	54.9M	33.6M
Short Term Investments	82.4M	55.2M	57.2M	65.5M	77.5M	53.6M
Liabilities And Stockholders Equity	121.6M	88.2M	125.1M	102.4M	120.2M	106.8M
Non Current Liabilities Total	369.8K	253.8K	1.1M	1.0M	782.6K	743.5K
Capital Lease Obligations	845.9K	559.0K	1.4M	1.4M	1.1M	649.5K
Other Current Assets	1.3M	3.7M	11.0M	14.2M	4.0M	4.3M
Other Stockholder Equity	213.2M	216.6M	283.4M	289.8M	341.7M	210.9M
Total Liab	14.4M	10.4M	19.9M	14.1M	17.6M	14.7M
Long Term Investments	272.6K	272.3K	27.2M	2.9M	9.1M	4.9M
Property Plant And Equipment Gross	1.4M	955.0K	1.7M	1.6M	4.3M	4.5M
Total Current Assets	119.0M	86.3M	95.7M	97.4M	109.5M	100.6M
Accumulated Other Comprehensive Income	25.1M	26.3M	30.6M	36.6M	40.1M	30.9M
Non Current Liabilities Other	(1.0)	33.3K	35.0K	36.9K	42.4K	44.5K
Short Term Debt	515.2K	338.5K	366.2K	369.4K	374.3K	275.1K
Intangible Assets	452.4K	350.2K	235.2K	138.9K	42.8K	40.7K
Common Stock	3.1M	3.4M	5.3M	5.4M	7.1M	3.7M
Property Plant Equipment	624.7K	1.4M	955.0K	1.7M	1.9M	2.0M
Net Invested Capital	107.1M	77.9M	105.3M	88.3M	102.6M	85.9M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for InflaRx Stock Analysis

When running InflaRx NV's price analysis, check to measure InflaRx NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InflaRx NV is operating at the current time. Most of InflaRx NV's value examination focuses on studying past and present price action to predict the probability of InflaRx NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InflaRx NV's price. Additionally, you may evaluate how the addition of InflaRx NV to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

InflaRx Research Development vs Operating Income Analysis

Research Development vs Operating Income

Research Development vs Operating Income Correlation Analysis

Correlation Coefficient

Research Development

Operating Income

InflaRx NV fundamental ratios Correlations

InflaRx NV Account Relationship Matchups

High Positive Relationship

High Negative Relationship

InflaRx NV fundamental ratios Accounts

Also Currently Popular

Additional Tools for InflaRx Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Long Term Debt Total	+ 1.0	Short Long Term Debt Total
Non Current Liabilities Total	+ 1.0	Short Long Term Debt Total
Net Tangible Assets	+ 1.0	Total Stockholder Equity
Long Term Investments	+ 1.0	Non Current Assets Total
Non Current Liabilities Total	+ 1.0	Long Term Debt Total
Total Stockholder Equity	+ 0.99	Total Assets

Cash	- 1.0	Net Debt
Property Plant And Equipment Gross	- 0.9	Retained Earnings
Other Stockholder Equity	- 0.9	Retained Earnings
Net Receivables	- 0.9	Retained Earnings
Retained Earnings	- 0.9	Property Plant And Equipment Net
Retained Earnings	- 0.9	Total Current Liabilities